CAS 2580154-02-3

L-Cysteinamide, N-acetyl-L-cysteinyl-L-arginylglycyl-L-α-aspartyl-L-lysylglycyl-L-prolyl-L-α-aspartyl-, cyclic (1→9)-disulfide

Description:

L-Cysteinamide, N-acetyl-L-cysteinyl-L-arginylglycyl-L-α-aspartyl-L-lysylglycyl-L-prolyl-L-α-aspartyl-, cyclic (1→9)-disulfide is a complex peptide that features a cyclic disulfide bond, which is significant for its structural stability and biological activity. This compound is characterized by the presence of multiple amino acid residues, including cysteine, arginine, glycine, aspartic acid, lysine, and proline, contributing to its diverse functional properties. The N-acetyl modification enhances its solubility and bioavailability, while the cyclic structure can influence its interaction with biological targets, potentially enhancing its efficacy in various biochemical pathways. Such peptides are often studied for their roles in cellular signaling, antioxidant activity, and potential therapeutic applications. The cyclic disulfide linkage is particularly important as it can confer resistance to enzymatic degradation, making it a candidate for drug development. Overall, this compound exemplifies the intricate relationship between structure and function in peptide chemistry.

Formula: C₃₇H₆₀N₁₄O₁₄S₂

Synonyms:

• Certepetide
• L-Cysteinamide, N-acetyl-L-cysteinyl-L-arginylglycyl-L-α-aspartyl-L-lysylglycyl-L-prolyl-L-α-aspartyl-, cyclic (1→9)-disulfide

Certepetide

CAS: 2580154-02-3

Certepetide, or iRGD, is a cyclic peptide that enhances tumor penetration and researches solid cancers.

Formula: C₃₇H₆₀N₁₄O₁₄S₂

Color and Shape: Solid

Molecular weight: 989.09

Ref: TM-T76255

Certepetide

CAS: 2580154-02-3

Certepetide

Purity: 98%

Molecular weight: 989.1g/mol

Ref: 54-OR1067159